Global Market
Medical Equipment

How is the Transcatheter Aortic Valve Replacement Market Poised for Growth: Trends and Opportunities Through 2034

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Transcatheter Aortic Valve Replacement Market Over the Coming Decade?

The transcatheter aortic valve replacement (TAVR) market has been expanding rapidly. It is forecasted to grow from $5.19 billion in 2024 to $5.91 billion in 2025 at a CAGR of 13.9%. The primary contributors to this growth include the increasing prevalence of aortic regurgitation and cardiovascular diseases, a growing preference for minimally invasive procedures, the global expansion of TAVR procedures, and favorable reimbursement policies.

The transcatheter aortic valve replacement market size is anticipated to grow rapidly, reaching $9.97 billion in 2029 at a CAGR of 14.0%. This growth is driven by the increasing prevalence of aortic stenosis, greater adoption of minimally invasive procedures, expanding indications for TAVR procedures, favorable reimbursement policies, and heightened awareness of TAVR as an effective treatment option. Key trends include continuous advancements in device technology, the rising burden of cardiovascular diseases, global expansion of TAVR procedures, an aging population, and increased healthcare spending.

How Are the key drivers Contributing to the Expansion of the Market?

The growing prevalence of aortic stenosis is one of the key factors influencing the transcatheter aortic valve replacement market in the future. Aortic stenosis is a medical condition characterized by the narrowing of the aortic valve in the heart. It can be treated using transcatheter aortic valve replacement (TAVR), which is a less invasive alternative to surgical aortic valve replacement (SAVR) that helps restore blood flow and alleviate symptoms of aortic valve stenosis. For example, in May 2024, data from the American Heart Association, a US-based nonprofit organization, indicated that over 12% of older Americans suffer from aortic stenosis, a condition frequently found in individuals over 65 years old. If untreated, it can lead to heart failure and can be fatal. Furthermore, in March 2023, a report from the National Institute for Health and Care Excellence (NICE), a public organization in the UK, stated that approximately 1.5% of people over 55 in the UK, or around 300,000 individuals, have severe aortic stenosis, with just under 200,000 experiencing symptomatic disease that necessitates treatment, contributing to over 380,000 people on cardiac waiting lists by March 2023. Therefore, the increase in aortic stenosis prevalence is driving the transcatheter aortic valve replacement market.

Get Your Free Sample of the Global Transcatheter Aortic Valve Replacement Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12031&type=smp

What Are the Major Players Making an Impact in the Transcatheter Aortic Valve Replacement Market’s Growth?

Major companies operating in the transcatheter aortic valve replacement market include:

• Abbott Laboratories Inc._x000D_

• Medtronic plc_x000D_

• Boston Scientific Corporation_x000D_

• Edwards Lifesciences Corporation_x000D_

• LivaNova PLC_x000D_

Which Upcoming Trends Are Set to Influence the Transcatheter Aortic Valve Replacement Market’s Path Forward?

Product innovation is a critical trend in the transcatheter aortic valve replacement (TAVR) market, with companies focusing on technological advancements to maintain their market position. In May 2024, Edwards Lifesciences, a US-based medical technology company, launched the Sapien 3 Ultra Resilia valve in Europe. This TAVR system integrates the company’s proprietary Resilia tissue technology, designed to extend valve longevity. Using bovine pericardial tissue treated with anti-calcification methods, the Resilia platform reduces structural valve deterioration, a primary cause of reintervention after valve replacement.

Get Instant Access to the Global Transcatheter Aortic Valve Replacement Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/transcatheter-aortic-valve-replacement-global-market-report

What Are the Strategic Segments Comprising the Transcatheter Aortic Valve Replacement Market and Their Growth Contributions?

The transcatheter aortic valve replacement market covered in this report is segmented –

1) By Product: Self-Expandable Transcatheter Aortic Valves, Balloon-Expandable Transcatheter Aortic Valves, Mechanically Expanded Transcatheter Aortic Valves

2) By Material: Valve Frame Material, Valve Leaflet Material

3) By Procedure: Transfemoral Implantation, Transapical Implantation, Transaortic Implantation

4) By Application: Aortic Stenosis, Aortic Regurgitation, Other Applications

5) By End-User: Hospitals, Independent Cardiac Catheterization Labs, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Self-Expandable Transcatheter Aortic Valves: Nitinol Frame Self-Expandable Valves, Polyester and Polyurethane Coated Valves

2) By Balloon-Expandable Transcatheter Aortic Valves: Balloon-Expandable Valves with Stent Design, Resilient Balloon-Expandable Valves

3) By Mechanically Expanded Transcatheter Aortic Valves: Manually Expanded Valves, Mechanically Operated Valve Systems

What Regions Are Steering Growth in the Transcatheter Aortic Valve Replacement Sector?

North America was the largest region in the transcatheter aortic valve replacement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter aortic valve replacement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can We Define the Transcatheter Aortic Valve Replacement Market and Its Key Components?

Transcatheter aortic valve replacement (TAVR), also known as transcatheter aortic valve implantation (TAVI), is a minimally invasive medical procedure used to replace a diseased or malfunctioning aortic valve in the heart. It can be performed on adults who are not in good enough health to undergo standard valve surgery.

Browse Through More Similar Reports By The Business Research Company:

Automotive Repair and Maintenance Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-repair-and-maintenance-global-market-report

Automobile Rental And Leasing Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery

https://www.thebusinessresearchcompany.com/report/automobile-rental-and-leasing-market

Automobiles And Heavy Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automobiles-and-heavy-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *